FDA advisers narrowly endorse Merck’s COVID-19 antiviral pill
An advisory group for the Food and Drug Administration (FDA) has voted to recommend Merck’s COVID-19 antiviral pill for infected adults at high risk for severe coronavirus illness, hospitalization or death.